Net Cash Provided by (Used in) Operating Activities |
8.18M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-426K |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-1.56M |
USD |
-233% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
12.2M |
shares |
+0.06% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
6.19M |
USD |
|
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
17.3M |
USD |
-19.6% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
964K |
USD |
+40.5% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
28M |
USD |
+29.3% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Deferred Tax Assets, Gross |
29.8M |
USD |
+19.7% |
Dec 31, 2023 |
Q4 2023 |
Payments to Acquire Property, Plant, and Equipment |
0 |
USD |
-100% |
Mar 31, 2022 |
Q1 2022 |
Deferred Income Tax Expense (Benefit) |
-17K |
USD |
+99.8% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
1K |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current Income Tax Expense (Benefit) |
26K |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Authorized |
10M |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Outstanding |
1K |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
1.76M |
USD |
-45.3% |
Dec 31, 2023 |
Q4 2023 |
Interest Expense |
3.4M |
USD |
+15.3% |
Mar 31, 2024 |
Q1 2024 |